OncoCyte's market cap is currently ―. The company's EPS TTM is $-23.737; its P/E ratio is -0.11; OncoCyte is scheduled to report earnings on May 14, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 429.00K	$ 463.00K	$ 297.00K	$ -3.55M	$ 1.02M
Gross Profit	$ 270.00K	$ 272.00K	$ 10.00K	$ 2.00M	$ -1.17M
EBIT	$ -6.61M	$ -8.33M	$ 5.96M	$ 9.32M	$ -9.32M
EBITDA	$ -6.18M	$ -7.88M	$ 6.43M	$ 8.49M	$ -7.95M
Net Income Common Stockholders	$ -6.69M	$ -8.64M	$ 1.63M	$ -45.29M	$ -9.55M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 14.24M	$ 17.87M	$ 12.40M	-	$ 32.47M
Total Assets	$ 81.59M	$ 87.51M	$ 82.80M	-	$ 157.34M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 3.76M
Net Debt	$ -14.24M	$ -17.87M	$ -12.40M	$ 0.00	$ -28.71M
Total Liabilities	$ 39.10M	$ 43.94M	$ 39.34M	-	$ 80.49M
Stockholders Equity	$ 37.56M	$ 43.58M	$ 37.93M	-	$ 76.86M
Cash Flow	-
Free Cash Flow	$ -2.04M	$ -8.49M	$ 8.67M	$ -10.45M	$ -12.21M
Operating Cash Flow	$ -2.26M	$ -8.61M	$ 8.67M	$ -9.65M	$ -11.35M
Investing Cash Flow	$ -1.30M	$ 1.92M	$ -18.31M	$ -802.00K	$ -859.00K
Financing Cash Flow	$ -30.00K	$ 12.27M	$ -28.00K	$ -100.00K	$ -572.00K

Currency in USD

OncoCyte Earnings and Revenue History

Income Statement >

OncoCyte Debt to Assets

Balance Sheet >

OncoCyte Cash Flow

Cash Flow >

OncoCyte Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing